查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1820449

2025 年至 2033 年乳房 X 光攝影市場規模、佔有率、趨勢及按技術、產品和地區分類的預測

Mammography Market Size, Share, Trends and Forecast by Technology, Product, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球乳房 X 光攝影市場規模為 26.4 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 50.6 億美元，2025 年至 2033 年的複合年成長率為 7.13%。北美目前佔據市場主導地位，2024 年的市佔率為 43.9%。乳癌發生率上升、人們對早期發現的認知不斷提高以及政府支持定期篩檢計畫的舉措推動了市場的發展。3D (3D) 斷層合成和人工智慧 (AI) 整合等技術進步提高了診斷準確性並促進了採用。不斷成長的醫療支出、不斷擴大的老年人口以及完善的報銷政策進一步鞏固了乳房 X 光攝影的市場佔有率。此外，向微創診斷程序的轉變和常規健康檢查參與度的提高對市場成長做出了重要貢獻，使乳房 X 光攝影成為癌症治療的重要工具。

推動乳房 X 光攝影市場發展的一大主要因素是全球乳癌發生率的上升，這刺激了對早期檢測和篩檢解決方案的強勁需求。僅在 2022 年，全球就診斷出約 230 萬例乳癌新病例，導致約 67 萬人死亡，凸顯了及時診斷的緊迫性。乳癌仍然是女性最常見的癌症之一，這促使醫療保健系統優先考慮早期檢測策略，以改善存活結果。越來越多的宣傳活動和教育計畫正在鼓勵更多女性定期接受篩檢。此外，各國政府和醫療保健組織正在擴大篩檢計畫和報銷支持，以確保更高的可及性。這些舉措將乳房 X 光攝影定位為重要的診斷工具，推動了乳房 X 光攝影市場的持續成長。

美國憑藉其先進的醫療基礎設施、較高的乳癌發生率以及對早期發現的高度重視，在乳房 X 光攝影市場佔據主導地位，市場佔有率達 88.20%。 2023 年，約有 79.8% 的 50-74 歲女性在過去兩年內接受了乳房 X 光攝影，這突顯了在宣傳活動、政府支持的篩檢計畫以及優惠的報銷政策的推動下，乳房 X 光攝影的廣泛應用。市場受益於先進技術的快速融合，包括 3D 數位乳房 X 光攝影和人工智慧成像，這些技術提高了診斷的準確性。龐大的女性老化人口和不斷成長的醫療支出進一步刺激了需求。正在進行的研究、創新和臨床試驗不斷增強乳房影像能力，確保美國在全球乳房 X 光攝影市場前景中保持領先地位。

乳房X光檢查市場趨勢：

乳房X光檢查技術進步

乳房X光檢查的普及在很大程度上得益於技術的快速進步，尤其是3D數位乳房斷層合成、全視野數位乳房X光檢查和人工智慧成像分析等創新技術。這些尖端解決方案能夠提供更清晰、更詳細的乳房影像，減少假陽性和不必要的活體組織切片，從而顯著提高診斷準確性。例如，3D乳房X光檢查使放射科醫生能夠逐層檢查乳房組織，從而提高癌症檢出率，尤其對於乳房組織緻密的女性而言。人工智慧的整合使放射科醫生能夠更有效率地解讀結果，減輕工作量，同時提高檢測信心。這些進步增強了患者和醫生對乳房X光檢查的信任，從而提高了其普及率。此外，主要產業參與者的持續研發確保了更先進、更便利、更具成本效益的系統不斷推出。持續的技術進步不僅解決了診斷難題，也加速了市場成長。

乳癌發生率上升

全球乳癌盛行率的上升是乳房X光檢查市場的重要趨勢。乳癌仍然是女性最常見的癌症，每年報告的新增病例數百萬，因此早期發現是醫療保健的首要任務。早期發現可顯著改善預後，在篩檢陽性族群中，早期確診的女性五年存活率超過90%。乳房X光檢查仍然是乳癌篩檢的黃金標準，使臨床醫生能夠在更容易治療的階段發現腫瘤。日益加重的疾病負擔促使各國政府、非政府組織和醫療機構在全球加強宣傳活動，並實施大規模篩檢計畫。隨著越來越多的女性意識到定期體檢的重要性，乳房X光檢查的普及率正在穩步上升。此外，醫療機構正在擴大診斷設施，提高其可近性，並強化乳房X光檢查在降低全球乳癌死亡率方面的重要作用。

政府措施和篩選項目

政府措施和大規模篩檢計畫在推動乳房 X 光攝影市場發展方面發揮著至關重要的作用，確保了乳房 X 光攝影的廣泛可及性和可負擔性。許多國家都推出了國家乳癌篩檢指南，強製或建議特定年齡層的女性定期進行乳房 X 光攝影。公共衛生運動強調早期發現的重要性，並鼓勵人們參與常規篩檢。此外，政府的資金、補貼和報銷政策也使原本可能面臨經濟障礙的人更容易獲得乳房 X 光攝影服務。例如，美國和歐洲等已開發國家的醫療改革確保了年度或兩年一次的篩檢覆蓋，這顯著刺激了需求。在發展中地區，國際合作和非政府組織推動的計畫幫助建立了篩檢設施和移動乳房 X 光攝影站，涵蓋服務匱乏的地區。這些措施不僅提高了公眾意識和可近性，也使常規篩檢實踐規範化，將乳房 X 光攝影定位為全球預防性醫療保健的基石。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球乳房X光檢查市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • 乳房斷層攝影
  • 電腦輔助設計
  • 數位的

第7章：市場區隔：依產品

  • 電影螢幕系統
  • 數位系統
  • 類比系統
  • 切片系統
  • 3D系統

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Analogic Corporation
    • Carestream Health (Onex Corporation)
    • Fujifilm Holdings Corporation
    • General Electric Company
    • Hologic Inc.
    • Konica Minolta Inc.
    • Metaltronica SpA
    • Mindray Medical International Limited
    • Koninklijke Philips NV
    • Planmed Oy (Planmeca Oy)
    • Siemens AG
Product Code: SR112025A3984

The global mammography market size was valued at USD 2.64 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.06 Billion by 2033, exhibiting a CAGR of 7.13% from 2025-2033. North America currently dominates the market, holding a market share of 43.9% in 2024. The market is driven by the rising prevalence of breast cancer, increasing awareness about early detection, and government initiatives supporting regular screening programs. Technological advancements, such as three-dimensional (3D) tomosynthesis and artificial intelligence (AI) integration, enhance diagnostic accuracy and fuel adoption. Growing healthcare expenditure, an expanding elderly population, and improved reimbursement policies further bolsters the mammography market share. Additionally, the shift toward minimally invasive diagnostic procedures and increased participation in routine health check-ups contribute significantly to market growth, making mammography an essential tool in cancer care.

One major driver in the mammography market is the rising prevalence of breast cancer worldwide, which has fueled strong demand for early detection and screening solutions. In 2022 alone, approximately 2.3 million new breast cancer cases were diagnosed globally, leading to around 670,000 deaths, highlighting the urgency of timely diagnosis. Breast cancer remains one of the most common cancers among women, prompting healthcare systems to prioritize early detection strategies to improve survival outcomes. Growing awareness campaigns and education programs are encouraging more women to undergo regular screenings. Additionally, governments and healthcare organizations are expanding screening initiatives and reimbursement support, ensuring greater accessibility. This emphasis positions mammography as a critical diagnostic tool, driving consistent mammography market growth.

The U.S. holds a dominant position in the mammography market with a share of 88.20%, supported by its advanced healthcare infrastructure, high breast cancer incidence, and strong focus on early detection. In 2023, approximately 79.8% of women aged 50-74 underwent a mammogram within the past two years, highlighting widespread adoption driven by awareness campaigns, government-supported screening programs, and favorable reimbursement policies. The market benefits from rapid integration of advanced technologies, including 3D digital mammography and AI-powered imaging, which enhance diagnostic accuracy. A large aging female population and rising healthcare spending further fuel demand. Ongoing research, innovation, and clinical trials continue to strengthen breast imaging capabilities, ensuring sustained U.S. leadership in the global mammography market outlook.

Mammography Market Trends:

Technological Advancements in Mammography

The adoption of mammography is strongly driven by rapid technological advancements, particularly innovations like 3D digital breast tomosynthesis, full-field digital mammography, and AI-powered imaging analysis. These cutting-edge solutions significantly enhance diagnostic accuracy by providing clearer, more detailed breast images, reducing false positives and unnecessary biopsies. For example, 3D mammography allows radiologists to examine breast tissue layer by layer, improving cancer detection rates, especially in women with dense breast tissue. The integration of artificial intelligence supports radiologists in interpreting results more efficiently, reducing workload while improving detection confidence. Such advancements have boosted patient and physician trust in mammography, leading to higher adoption rates. Moreover, continuous research and development by key industry players ensure that more sophisticated, user-friendly, and cost-effective systems are introduced. This ongoing technological progress not only addresses diagnostic challenges but also accelerates market growth.

Rising Prevalence of Breast Cancer

The increasing global prevalence of breast cancer is a key mammography market trend. Breast cancer remains the most commonly diagnosed cancer among women, with millions of new cases reported annually, making early detection a crucial healthcare priority. Early detection greatly improves outcomes, as five-year survival rates exceed 90% for women diagnosed at earlier stages in screening-positive populations. Mammography continues to serve as the gold standard for breast cancer screening, enabling clinicians to identify tumors at more treatable stages. The growing disease burden has pushed governments, NGOs, and healthcare organizations to intensify awareness campaigns and implement large-scale screening programs worldwide. As more women understand the importance of regular check-ups, adoption of mammography is steadily rising. Additionally, healthcare providers are expanding diagnostic facilities, enhancing accessibility and reinforcing mammography's essential role in reducing global breast cancer mortality rates.

Government Initiatives and Screening Programs

Government initiatives and large-scale screening programs play a vital role in driving the mammography market by ensuring widespread access and affordability. Many countries have introduced national breast cancer screening guidelines, mandating or recommending regular mammograms for women in specific age groups. Public health campaigns emphasize the importance of early detection, encouraging participation in routine screenings. Additionally, government funding, subsidies, and reimbursement policies make mammography more accessible to populations that might otherwise face financial barriers. For instance, healthcare reforms in developed nations like the U.S. and Europe ensure coverage for annual or biennial screenings, significantly boosting demand. In developing regions, international collaborations and NGO-driven programs help establish screening facilities and mobile mammography units to reach underserved areas. These initiatives not only increase awareness and access but also normalize routine screening practices, positioning mammography as a cornerstone of preventive healthcare worldwide.

Mammography Industry Segmentation:

Analysis by Technology:

  • Breast Tomosynthesis
  • CAD
  • Digital

According to the mammography market forecast, the digital mammography accounts for the majority of the market share of 64.8%, driven by its ability to deliver high-resolution images, faster results, and enhanced diagnostic precision compared to analog systems. The technology's compatibility with advanced tools such as 3D breast tomosynthesis and AI-driven image analysis further strengthens its clinical value, making it the preferred choice among healthcare providers. Additionally, digital systems streamline workflow efficiency through easy image storage, retrieval, and sharing, reducing delays in diagnosis and treatment. Lower radiation doses, improved patient comfort, and higher detection rates in dense breast tissues contribute to widespread adoption. Supportive government initiatives, reimbursement policies, and the growing demand for advanced screening solutions ensure that digital mammography continues to dominate global market share.

Analysis by Product:

  • Film Screen Systems
  • Digital Systems
  • Analog Systems
  • Biopsy Systems
  • 3D Systems

Digital systems dominate the mammography market demand with a market share of 59.8%, driven by their superior image quality, faster processing, and improved diagnostic accuracy compared to traditional film-based systems. They enable efficient storage, retrieval, and sharing of images through picture archiving and communication systems (PACS), supporting streamlined workflows and remote consultations. Digital mammography also facilitates advanced technologies like 3D tomosynthesis and AI integration, enhancing early cancer detection and reducing false positives. Hospitals and diagnostic centers prefer these systems due to lower long-term operational costs, reduced radiation exposure, and higher patient throughput. Growing awareness, government support, and reimbursement for digital screenings further accelerate adoption, solidifying digital mammography's position as the standard choice in modern breast imaging practices.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Based on the mammography market analysis, North America is the leading region with a market share of 43.9% driven by its advanced healthcare infrastructure, high adoption of cutting-edge imaging technologies, and strong emphasis on early breast cancer detection. The region benefits from widespread awareness campaigns, supportive government policies, and comprehensive reimbursement systems that encourage routine screenings. A significant prevalence of breast cancer, coupled with a growing aging population, fuels continuous demand for mammography services. Additionally, rapid integration of innovations such as 3D tomosynthesis and AI-based imaging strengthens diagnostic capabilities and patient confidence. Strong investments in research, clinical trials, and healthcare digitization further contribute to the region's dominance, positioning North America as a global hub for mammography advancements and early detection initiatives.

Key Regional Takeaways:

United States Mammography Market Analysis

The United States mammography market is primarily driven by the increasing awareness about the importance of early breast cancer detection. In line with this, continual technological advancements such as digital mammography and 3D imaging, enhancing diagnostic accuracy and precision, are impelling the market. The growing aging population is also contributing to a higher incidence of breast cancer, further fueling market demand. According to the U.S. Census Bureau's Vintage 2024 Population Estimates, the U.S. population aged 65 and older increased by 3.1%, reaching 61.2 million, while the population under age 18 decreased by 0.2%, totaling 73.1 million, from 2023 to 2024. Additionally, supportive government initiatives and the expansion of insurance coverage for preventive care are stimulating market appeal. The rising healthcare expenditure in the U.S., which enables greater investments in advanced imaging systems, is propelling market growth. Furthermore, the heightened prevalence of dense breast tissue, which drives the need for specialized imaging solutions, is fostering market expansion. The rapid integration of artificial intelligence in mammography is improving both diagnostic speed and accuracy. Moreover, the increasing focus on women's health and wellness is creating lucrative opportunities in the market.

Europe Mammography Market Analysis

The European market is experiencing growth attributed to the increasing prevalence of breast cancer. Europe, representing 9% of the global population, accounts for 20.3% of cancer deaths and 23.4% of diagnoses. As per the European Cancer Information System, in 2022, 2.74 million new cancer cases were reported, with projections indicating over 3.24 million cases by 2040, highlighting the need for early detection. In accordance with this, the increasing adoption of advanced digital and 3D mammography technologies is improving diagnostic accuracy and market accessibility. The rising focus on preventive healthcare programs is further enhancing screening rates. Similarly, the expansion of public and private insurance coverage is making mammography more affordable, contributing to market growth. The ongoing integration of artificial intelligence in mammography systems, which optimizes diagnostic processes and reduces human error, is strengthening market demand. Furthermore, increasing awareness of women's health and wellness, driving more initiatives aimed at breast cancer prevention, is enhancing market appeal. The aging population in Europe, which faces a higher risk of breast cancer, is also contributing to the market development. Besides this, strategic investments in healthcare infrastructure are accelerating the adoption of these advanced screening technologies.

Asia Pacific Mammography Market Analysis

The mammography market in the Asia Pacific is largely propelled by the rising prevalence of breast cancer, which is increasing the demand for early detection solutions. According to NCBI, breast cancer is a major health issue in Asia, with an estimated 985.4 thousand new cases and 315.1 thousand deaths reported in 2022. The age-standardized incidence and mortality rates are 34.3 and 10.5 per 100,000, respectively, highlighting the critical need for effective screening and early detection. Additionally, continuous improvements in healthcare infrastructure are enhancing access to advanced diagnostic technologies like digital mammography. The strong government initiatives and public health campaigns are further encouraging regular breast screenings. Furthermore, the growing awareness among women about breast cancer prevention is contributing to the increased adoption of mammography services. The increasing availability and affordability of advanced imaging technologies are augmenting market growth. Moreover, the expansion of private healthcare facilities offering specialized diagnostic services is improving access to high-quality mammography, thereby impacting the market trends.

Latin America Mammography Market Analysis

In Latin America, the market is expanding due to increasing healthcare investments aimed at improving cancer detection services. As such, in January 2025, Mamotest secured a USD 1.5 Million investment from Philips Foundation to scale AI-driven breast cancer care. The funding will enhance diagnostics, improve patient outcomes, and expand Mamotest's reach in Latin America and Europe, benefiting underserved populations. Similarly, the rising awareness campaigns focused on breast cancer prevention are encouraging women to undergo regular screenings. The expansion of healthcare insurance coverage is increasing access to mammography, particularly in underserved areas. Moreover, the growing adoption of advanced imaging technologies, such as digital and 3D mammography, is improving diagnostic accuracy and fueling demand for more effective screening solutions, providing an impetus to the market.

Middle East and Africa Mammography Market Analysis

The mammography market in the Middle East and Africa is influenced by the rising healthcare investments in both public and private sectors, enhancing access to advanced diagnostic tools. Similarly, favorable government initiatives promoting women's health and preventive care are further supporting market demand. The heightened awareness of breast cancer prevention, leading to higher screening rates, is fostering market expansion. In Saudi Arabia, breast cancer is the most common cancer among women. A study in Arar City showed 84.2% awareness of breast self-examination (BSE), with 80% of participants having good knowledge of BSE and mammography. Furthermore, the growing adoption of mobile health solutions and telemedicine is expanding access to mammography services, especially in remote areas.

Competitive Landscape:

The competitive landscape is characterized by intense innovation, technological advancement, and strategic expansion. Market players focus heavily on developing advanced imaging solutions, such as 3D tomosynthesis, digital breast imaging, and AI-powered diagnostic tools, to improve accuracy and efficiency. Competition is fueled by the rising demand for early detection technologies, pushing companies to enhance product portfolios and invest in research and development (R&D). Additionally, partnerships with healthcare providers, regulatory approvals, and global distribution networks are crucial strategies for gaining market share. The landscape also reflects a balance between established manufacturers offering premium solutions and emerging players providing cost-effective alternatives, creating a dynamic environment that drives continuous technological progress and accessibility worldwide.

The report provides a comprehensive analysis of the competitive landscape in the mammography market with detailed profiles of all major companies.

Key Questions Answered in This Report

  • 1.How big is the mammography market?
  • 2.What is the future outlook of mammography market?
  • 3.What are the key factors driving the mammography market?
  • 4.Which region accounts for the largest mammography market share?
  • 5.Which are the leading companies in the global mammography market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Mammography Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Breast Tomosynthesis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CAD
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Digital
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Film Screen Systems
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Digital Systems
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Analog Systems
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopsy Systems
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 3D Systems
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Analogic Corporation
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 SWOT Analysis
    • 13.3.2 Carestream Health (Onex Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Fujifilm Holdings Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 General Electric Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Hologic Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Konica Minolta Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Metaltronica S.p.A.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Mindray Medical International Limited
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Planmed Oy (Planmeca Oy)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Siemens AG
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Mammography Market: Major Drivers and Challenges
  • Figure 2: Global: Mammography Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Mammography Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Mammography Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Mammography Market: Breakup by Product (in %), 2024
  • Figure 6: Global: Mammography Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Mammography (Breast Tomosynthesis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Mammography (Breast Tomosynthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Mammography (CAD) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Mammography (CAD) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Mammography (Digital) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Mammography (Digital) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Mammography (Film Screen Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Mammography (Film Screen Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Mammography (Digital Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Mammography (Digital Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Mammography (Analog Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Mammography (Analog Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Mammography (Biopsy Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Mammography (Biopsy Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Mammography (3D Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Mammography (3D Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Mammography Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Mammography Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Mammography Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Mammography Industry: SWOT Analysis
  • Figure 73: Global: Mammography Industry: Value Chain Analysis
  • Figure 74: Global: Mammography Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Mammography Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Mammography Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Mammography Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 4: Global: Mammography Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Mammography Market: Competitive Structure
  • Table 6: Global: Mammography Market: Key Players